Minimally Invasive TLIF - Reducing Length of Stay and Early Return to Function

WEBINAR

Minimally Invasive TLIF - Reducing Length of Stay and Early Return to Function

Faculty: Praveen Mummaneni, Clinton Devin, Brian Kwon, Sheeraz Qureshi

Notification icon This webinar took place on 
http://www.vumedi.com/webinar/minimally-invasive-tlif-reducing-length-of-stay-and-early-return-to-function/
Sponsors

This activity is supported by an independent educational grant from

Program

Praveen Mummaneni

UCSF Medical Center, San Francisco, CA.

MIS Approach to TLIF

Clinton Devin

Vanderbilt University Medical Center, Nashville, TN.

Minimizing Opioid Consumption Prior to Surgery

Brian Kwon

Tufts University School of Medicine, Boston, MA.

Pain Management Strategies to Reduce Hospital Stay

Sheeraz Qureshi

Mount Sinai Hospital, New York, NY.

Outpatient MIS TLIF

Faculty:

  • Praveen Mummaneni

    UCSF Medical Center, San Francisco, CA.

  • Clinton Devin

    Vanderbilt University Medical Center, Nashville, TN.

  • Brian Kwon

    Tufts University School of Medicine, Boston, MA.

  • Sheeraz Qureshi

    Mount Sinai Hospital, New York, NY.

Release: 05/11/2016

Expiration: 05/18/2016

Location: Online

Requirements for successful completion: In order to receive credit, participants must view all audio-visual presentations and complete both the pre-test, post-test and evaluation form. Participants must score 100% on the activity post-test in order to receive credit. There are no pre-requisites for this activity. Course attendance verification forms are provided upon successful completion of the post-test and evaluation form. No partial credit will be given.

Target Audience: Physicians, residents and trainees, fellows, nurses, surgical techs, physical therapists, and other members of the allied health community whose scope of practice encompasses Orthopaedics.

Course Description: In this live webinar, expert Spine will present optimal operable techniques and treatment options to address Minimally Invasive TLIF - Reducing Length of Stay and Early Return to Function. The webinar features time for interactive audience discussion and surgical case based scenarios.

Learning Objectives: Upon completion of this activity, participants should be better able to discuss:

  1. Discuss the MIS TLIF approach and technique.
  2. Discuss steps to minimize opioid consumption prior to surgery.
  3. Discuss pain management strategies to reduce hospital stay.
  4. Discuss complications of MIS TLIF and how to minimize them.
  5. Discuss MIS TLIF surgery in the outpatient setting.

Credits: This lecture qualifies for 2 CME credit hours.

Cost: $0.0

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the International Institute for Continuing Medical Education and VuMedi. The International Institute for Continuing Medical Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide medical education to physicians.

Designation Statement: The International Institute for Continuing Medical Education, Inc designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures: Faculty Disclosures/Conflict of Interest Policy\nIn accordance with ACCME requirements, The International Institute for Continuing Medical Education, Inc, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by The International Institute for Continuing Medical Education, Inc. and conflicts of interest were resolved prior to the activity.

Dr. Praveen Mummaneni discloses the following relevant financial relationships with a commercial interest: Depuy Spine – Consultant, Other financial support (royalty), Quality Medical Publishers, Thieme Publishers – other financial support (royalty), AO Spine – Honoraria and grant, Spinicity/ISD - Stock

Dr. Clinton Devin discloses the following relevant financial relationships with a commercial interest: PACIRA RESEARCH SUPPORT 2. STRYKER SPINE RESEARCH SUPPORT 3. DEPUY RESIDENT LEADEARSHIP COURSE MODERATOR 4. MEDTRONIC PRODUCT DESIGN 5. DEFENSE EXPERT WITNESS.

Dr. Brian Kwon discloses the following relevant financial relationships with a commercial interest: Medtronic, Nuvasive, Speaking, consultant, travel, Zimmer/ETEX, Medical director, consultant, Pacira Pharmaceuticals, Consultant, Editorial Board, Journal Spine Disorders Techniques, Board Member, Korean American Spine Society.

Dr. Sheeraz Qureshi discloses the following relevant financial relationships with a commercial interest: Committee Appointments, AAOS Evaluations Committee, CSRS Program Committee, CSRS Survey Committee, NASS Value Committee, Journals, Spine Journal (Reviewer), Spine (Reviewer), CORR (Reviewer), Global Spine Journal Reviewer, Journal of American Academy of Orthopaedic Surgeons, Royalties, Zimmer, Stryker, Biomet, RTI, Consulting, Medtronic, Stryker, Biomet, RTI, Teaching, Medtronic, Stryker, Advisory Boards, MTF Medical Board of Directors, Pacira Spine Surgeon Advisory Board

Faculty Disclosures of Unlabeled Use: The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.


Dr. Praveen Mummaneni does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Clinton Devin does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Brian Kwon does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Sheeraz Qureshi does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Commercial Support: No commercial support was received for this activity.

Software Requirements: VuMedi Webinars supports the following web browsers (with enabled JavaScript™): Internet Explorer® versions 6.0, 7.0, 8.0, Mozilla Firefox versions 1.0, 2.0, 3.0, and Safari for Mac. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. That software may be: Adobe Acrobat®, Adobe® Flash Player, Microsoft® Office PowerPoint, and Microsoft® Office Word.These activities will be marked as such and will provide links to the required software.

Copyright: Any and/or all materials are for the exclusive use of the faculty and participants of the live activity. Any copying, duplicating or reproducing of any and/or all materials by electronic, mechanical or other means for any purpose other than this enduring activity is strictly prohibited without prior written consent of the author of those materials.

Policy on Privacy and Confidentiality: For more information regarding VuMedi's Policy on Privacy and Confidentiality, please visit http://www.vumedi.com/pages/privacy/

To Contact our Accredited Provider: 6438 US Hwy 11
Springville, AL 35146
Phone: (205) 467-0290
Fax: (205) 467-0195
email: iicmemail@gmail.com

For questions regarding this activity, please contact VuMedi: cme@vumedi.com


4 Comments
Login to view comments. Click here to Login